Send me real-time posts from this site at my email
Wild Tiger Trading

Trading List: Dec. 15 - Updates & Analyst Actions - TGTX

$TGTX - On our trading list with news today or analyst comments with our opinion & trade ideas.

TG Therapeutics prices their secondary offering at $43.50 with the deal size increased.

TG Therapeutics 6.32M share Secondary priced at $43.50

The deal size was increased to $275M from $200M and priced below the last closing price of $43.75. JPMorgan, Goldman Sachs, Evercore ISI and Cantor Fitzgerald are acting as joint book running managers for the offering.

Our Take:  A very successful offering with shares being placed only .25 cents below the closing market price. This also after jumping 40% last Thursday on very good MS drug trial results!  This remains our top pick.

Normally a secondary offering dilutes current shareholders, but in this case it is a positive as the shares were bought without a discount and raised a nice sum of cash for TGTX. :)

$TGTX, TG Therapeutics, Inc. / H1

Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal.

If you liked this article, please click the LIKE (thumbs up) button.

Feel free to leave any comments, question, or opinions. (Sign-up if you haven't already done so).

Follow us/bookmark us and check back occasionally for additional articles or comments on our page...

Wild Tiger Trading - start/main page.


Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue